Skip to Content


Advisory Committee; Renewals

Document Details

Information about this document as published in the Federal Register.

Published Document

This document has been published in the Federal Register. Use the PDF linked in the document sidebar for the official electronic format.

Start Preamble


Food and Drug Administration, HHS.




The Food and Drug Administration (FDA) is announcing the renewal of certain FDA advisory committees by the Commissioner of Food and Drugs (the Commissioner). The Commissioner has determined that it is in the public interest to renew the charters of the committees listed in the following table for an additional 2 years beyond charter expiration date. The new charters will be in effect until the dates of expiration listed in the following table. This notice is issued under the Federal Advisory Committee Act of October 6, 1972 (Public Law 92-463 (5 U.S.C. app. 2)).


Authority for these committees will expire on the dates indicated in the following table unless the Commissioner formally determines that renewal is in the public interest.

Name of committeeDate of expiration
Science Board to the Food and Drug AdministrationJune 26, 2004
Allergenic Products Advisory CommitteeJuly 9, 2004
Cardiovascular Drugs Advisory CommitteeAugust 27, 2004
Endocrinologic and Metabolic Drugs Advisory CommitteeAugust 27, 2004
Oncologic Drugs Advisory CommitteeSeptember 1, 2004
Anti-Infective Drugs Advisory CommitteeOctober 7, 2004
Dermatologic and Ophthalmic Drugs Advisory CommitteeOctober 7, 2004
Biological Response Modifiers Advisory CommitteeOctober 28, 2004
Technical Electronic Product Radiation Safety Standards CommitteeDecember 24, 2004
Antiviral Drugs Advisory CommitteeFebruary 15, 2005
Start Further Info Start Printed Page 12912


Linda A. Sherman, Advisory Committee Oversight and Management Staff (HF-4), Food and Drug Administration, 5600 Fishers Lane, Rockville, MD 20857, 301-827-1220.

End Further Info Start Signature

Dated: March 10, 2003.

Linda Arey Skladany,

Associate Commissioner for External Relations.

End Signature End Preamble

[FR Doc. 03-6397 Filed 3-17-03; 8:45 am]